TradingKey

关于 Quanterix Corp 公司

Quanterix Corporation 是一家生命科学公司。该公司致力于开发超灵敏数字免疫测定平台，以促进生命科学研究和诊断的精准健康。其平台基于其数字 Simoa 检测技术。其 Simoa 珠状和平面阵列平台使客户能够检测血液、血清和其他液体中低浓度的蛋白质生物标志物。该公司的 Simoa 技术基于传统的酶联免疫吸附测定 (ELISA) 技术。其产品包括 HD-X、SR-X、SP-X、Simoa 测定和耗材以及 NfL 抗体和 NfL ELISA 试剂盒。它还通过其加速器实验室为客户提供合同研究服务，该实验室为客户提供 Simoa 技术，并支持多个项目和服务，包括样品测试、自制测定开发和定制测定开发。它已经使用其 Simoa 平台为 480 个客户完成了 2,200 多个项目。

公司简介

公司代码QTRX

公司名称Quanterix Corp

上市日期Dec 07, 2017

CEODr. Masoud Toloue, Ph.D.

员工数量471

证券类型Ordinary Share

年结日Dec 07

公司地址900 Middlesex Turnpike

城市BILLERICA

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编01821

电话16173019400

网址https://www.quanterix.com/

公司代码QTRX

上市日期Dec 07, 2017

CEODr. Masoud Toloue, Ph.D.

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

--

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

--

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

19.42K

+62.04%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.28K

-2.41%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

--

Mr. Paul M. Meister

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

--

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

--

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

地区USD

名称

营收

占比

North America

19.38M

64.01%

EMEA

6.63M

21.92%

Asia Pacific

4.26M

14.07%

业务

地区

业务USD

名称

营收

占比

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

股东统计

更新时间: 8月2日周六

持股股东

股东类型

持股股东

占比

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

持股股东

占比

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

30.87%

Investment Advisor

25.39%

Hedge Fund

12.76%

Individual Investor

6.60%

Research Firm

3.49%

Pension Fund

0.35%

Bank and Trust

0.21%

Family Office

0.13%

Venture Capital

0.05%

Other

20.15%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

391

37.62M

83.70%

-11.91M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

2023Q1

389

37.25M

100.03%

-8.36M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Columbia Threadneedle Investments (UK)

3.00M

7.72%

+237.57K

+8.60%

Mar 31, 2025

Portolan Capital Management, L.L.C.

2.96M

7.63%

+375.57K

+14.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.68M

6.91%

-89.03K

-3.21%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

6.5%

+316.41K

+14.32%

Mar 31, 2025

Kent Lake PR LLC

2.92M

7.53%

+279.82K

+10.58%

Mar 31, 2025

Walt (David R)

1.86M

4.79%

+370.00K

+24.84%

Jun 13, 2025

William Blair Investment Management, LLC

1.11M

2.85%

+43.96K

+4.14%

Mar 31, 2025

UBS Financial Services, Inc.

1.11M

2.87%

+186.90K

+20.14%

Mar 31, 2025

Easterly Investment Partners LLC

1.33M

3.41%

+370.63K

+38.81%

Mar 31, 2025

Invenomic Capital Management LP

902.04K

2.32%

+546.67K

+153.83%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.58%

iShares Micro-Cap ETF

0.06%

Fidelity Enhanced Small Cap ETF

0.04%

Avantis US Small Cap Equity ETF

0.03%

iShares Biotechnology ETF

0.02%

iShares Russell 2000 Value ETF

0.02%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

Schwab U.S. Small-Cap ETF

0.01%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.58%

iShares Micro-Cap ETF

占比0.06%

Fidelity Enhanced Small Cap ETF

占比0.04%

Avantis US Small Cap Equity ETF

占比0.03%

iShares Biotechnology ETF

占比0.02%

iShares Russell 2000 Value ETF

占比0.02%

Invesco RAFI US 1500 Small-Mid ETF

占比0.02%

Schwab U.S. Small-Cap ETF

占比0.01%

Proshares Ultra Russell 2000

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Quanterix Corp

6.049USD

Quanterix Corp

6.049

概览

公司

财务